How could CRISPR-modified bacteriophages help destroy antibiotic-resistant bacteria?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

CRISPR-modified bacteriophages offer a promising precision approach to combating antibiotic-resistant bacteria. While natural phages are viruses that infect and kill specific bacteria, they can be engineered to enhance their efficacy against drug-resistant strains.1

By utilizing CRISPR-Cas technology, researchers can program these phages to carry specific genetic instructions into a target bacterium. Once inside, the CRISPR system acts as a molecular guided missile:

  • Targeted Destruction: The phage delivers a guide RNA that directs a nuclease (such as Cas9) to identify and cleave specific DNA sequences within the host bacterium.23
  • Disabling Resistance: By targeting the genes responsible for antibiotic resistance, the CRISPR-modified phage can effectively "disarm" the bacteria, rendering them susceptible to conventional antibiotics again or directly causing the death of the pathogen.31
  • Precision: Because each phage is highly specific to certain bacterial strains, this method minimizes damage to the beneficial microbiome, a significant advantage over broad-spectrum antibiotics.1

This approach represents a sophisticated application of genetic engineering to address the urgent global health challenge of antimicrobial resistance.31